Aclarubicin
Foscarnet may increase the nephrotoxic activities of Aclarubicin.
Amikacin
Foscarnet may increase the nephrotoxic activities of Amikacin.
Amiodarone
Foscarnet may increase the QTc-prolonging activities of Amiodarone.
Advertisement
Amphotericin B
Foscarnet may increase the nephrotoxic activities of Amphotericin B.
amphotericin B liposomal
Foscarnet may increase the nephrotoxic activities of Amphotericin B.
Anagrelide
Foscarnet may increase the QTc-prolonging activities of Anagrelide.
Advertisement
Anhydrous Tacrolimus
Foscarnet may increase the nephrotoxic activities of Tacrolimus.
Arbekacin
Foscarnet may increase the nephrotoxic activities of Arbekacin.
Arsenic Trioxide
Foscarnet may increase the QTc-prolonging activities of Arsenic trioxide.
Advertisement
Artemether
Foscarnet may increase the QTc-prolonging activities of Artemether.
Asenapine
Foscarnet may increase the QTc-prolonging activities of Asenapine.
Azithromycin
Foscarnet may increase the QTc-prolonging activities of Azithromycin.
Azosemide
Azosemide may decrease the excretion rate of Foscarnet which could result in a higher serum level.
Bedaquiline
Foscarnet may increase the QTc-prolonging activities of Bedaquiline.
Bumetanide
Bumetanide may decrease the excretion rate of Foscarnet which could result in a higher serum level.
Ceritinib
Foscarnet may increase the QTc-prolonging activities of Ceritinib.
Chloroquine
Foscarnet may increase the QTc-prolonging activities of Chloroquine.
Chlorpromazine
Foscarnet may increase the QTc-prolonging activities of Chlorpromazine.
Ciprofloxacin
Foscarnet may increase the QTc-prolonging activities of Ciprofloxacin.
Cisapride
Foscarnet may increase the QTc-prolonging activities of Cisapride.
Citalopram
Foscarnet may increase the QTc-prolonging activities of Citalopram.
Clarithromycin
Foscarnet may increase the QTc-prolonging activities of Clarithromycin.
Clozapine
Foscarnet may increase the QTc-prolonging activities of Clozapine.
Crizotinib
Foscarnet may increase the QTc-prolonging activities of Crizotinib.
Cyclosporine
Foscarnet may increase the nephrotoxic activities of Cyclosporine.
Daunorubicin
Foscarnet may increase the nephrotoxic activities of Daunorubicin.
Dihydrostreptomycin
Foscarnet may increase the nephrotoxic activities of Dihydrostreptomycin.
Disopyramide
Foscarnet may increase the QTc-prolonging activities of Disopyramide.
Dofetilide
Foscarnet may increase the QTc-prolonging activities of Dofetilide.
Dolasetron
Foscarnet may increase the QTc-prolonging activities of Dolasetron.
Domperidone
Foscarnet may increase the QTc-prolonging activities of Domperidone.
Doxorubicin
Foscarnet may increase the nephrotoxic activities of Doxorubicin.
Doxorubicin Hydrochloride
Foscarnet may increase the nephrotoxic activities of Doxorubicin.
Dronedarone
Foscarnet may increase the QTc-prolonging activities of Dronedarone.
Droperidol
Foscarnet may increase the QTc-prolonging activities of Droperidol.
Eliglustat
Foscarnet may increase the QTc-prolonging activities of Eliglustat.
Epirubicin
Foscarnet may increase the nephrotoxic activities of Epirubicin.
Erythromycin
Foscarnet may increase the QTc-prolonging activities of Erythromycin.
Escitalopram
Foscarnet may increase the QTc-prolonging activities of Escitalopram.
Ethacrynate
Etacrynic acid may decrease the excretion rate of Foscarnet which could result in a higher serum level.
Ethacrynic Acid
Etacrynic acid may decrease the excretion rate of Foscarnet which could result in a higher serum level.
Flecainide
Foscarnet may increase the QTc-prolonging activities of Flecainide.
Fluoxetine
Foscarnet may increase the QTc-prolonging activities of Fluoxetine.
Flupenthixol
Foscarnet may increase the QTc-prolonging activities of Flupentixol.
Framycetin
Foscarnet may increase the nephrotoxic activities of Framycetin.
Furosemide
Furosemide may decrease the excretion rate of Foscarnet which could result in a higher serum level.
Gadobenate
Foscarnet may increase the QTc-prolonging activities of Gadobenic acid.
Gemifloxacin
Foscarnet may increase the QTc-prolonging activities of Gemifloxacin.
Gemifloxacin Mesylate
Foscarnet may increase the QTc-prolonging activities of Gemifloxacin.
Gentamicin
Foscarnet may increase the nephrotoxic activities of Gentamicin.
Goserelin
Foscarnet may increase the QTc-prolonging activities of Goserelin.
Granisetron
Foscarnet may increase the QTc-prolonging activities of Granisetron.
Haloperidol
Foscarnet may increase the QTc-prolonging activities of Haloperidol.
Ibutilide
Foscarnet may increase the QTc-prolonging activities of Ibutilide.
Idarubicin
Foscarnet may increase the nephrotoxic activities of Idarubicin.
Iloperidone
Foscarnet may increase the QTc-prolonging activities of Iloperidone.
Kanamycin
Foscarnet may increase the nephrotoxic activities of Kanamycin.
kanamycin A
Foscarnet may increase the nephrotoxic activities of Kanamycin.
Lenvatinib
Foscarnet may increase the QTc-prolonging activities of Lenvatinib.
Lenvatinib Mesylate
Foscarnet may increase the QTc-prolonging activities of Lenvatinib.
Leuprolide
Foscarnet may increase the QTc-prolonging activities of Leuprolide.
Levofloxacin
Foscarnet may increase the QTc-prolonging activities of Levofloxacin.
Levofloxacin Anhydrous
Foscarnet may increase the QTc-prolonging activities of Levofloxacin.
Lopinavir
Foscarnet may increase the QTc-prolonging activities of Lopinavir.
Lumefantrine
Foscarnet may increase the QTc-prolonging activities of Lumefantrine.
Methadone
Foscarnet may increase the QTc-prolonging activities of Methadone.
Methotrexate
Foscarnet may increase the nephrotoxic activities of Methotrexate.
Metrizamide
Foscarnet may increase the nephrotoxic activities of Metrizamide.
Mifepristone
Mifepristone may increase the QTc-prolonging activities of Foscarnet.
Moxifloxacin
Foscarnet may increase the QTc-prolonging activities of Moxifloxacin.
Neomycin
Foscarnet may increase the nephrotoxic activities of Neomycin.
Netilmicin
Foscarnet may increase the nephrotoxic activities of Netilmicin.
Nilotinib
Foscarnet may increase the QTc-prolonging activities of Nilotinib.
Ofloxacin
Foscarnet may increase the QTc-prolonging activities of Ofloxacin.
Ondansetron
Foscarnet may increase the QTc-prolonging activities of Ondansetron.
Paliperidone
Foscarnet may increase the QTc-prolonging activities of Paliperidone.
Panobinostat
Foscarnet may increase the QTc-prolonging activities of Panobinostat.
Paromomycin
Foscarnet may increase the nephrotoxic activities of Paromomycin.
Pazopanib
Foscarnet may increase the QTc-prolonging activities of Pazopanib.
Pentamidine
The risk or severity of adverse effects can be increased when Pentamidine is combined with Foscarnet.
Perflutren
Foscarnet may increase the QTc-prolonging activities of Perflutren.
Pimozide
Foscarnet may increase the QTc-prolonging activities of Pimozide.
Pirarubicin
Foscarnet may increase the nephrotoxic activities of Pirarubicin.
Piretanide
Piretanide may decrease the excretion rate of Foscarnet which could result in a higher serum level.
Plicamycin
Foscarnet may increase the nephrotoxic activities of Plicamycin.
Primaquine
Foscarnet may increase the QTc-prolonging activities of Primaquine.
Procainamide
Foscarnet may increase the QTc-prolonging activities of Procainamide.
Promazine
Foscarnet may increase the QTc-prolonging activities of Promazine.
Propafenone
Foscarnet may increase the QTc-prolonging activities of Propafenone.
Quetiapine
Foscarnet may increase the QTc-prolonging activities of Quetiapine.
Quetiapine fumarate
Foscarnet may increase the QTc-prolonging activities of Quetiapine.
Quinidine
Foscarnet may increase the QTc-prolonging activities of Quinidine.
Quinine
Foscarnet may increase the QTc-prolonging activities of Quinine.
Saquinavir
Foscarnet may increase the QTc-prolonging activities of Saquinavir.
Saquinavir Mesylate
Foscarnet may increase the QTc-prolonging activities of Saquinavir.
Sisomicin
Foscarnet may increase the nephrotoxic activities of Sisomicin.
Sotalol
Foscarnet may increase the QTc-prolonging activities of Sotalol.
Spectinomycin
Foscarnet may increase the nephrotoxic activities of Spectinomycin.
Streptomycin
Foscarnet may increase the nephrotoxic activities of Streptomycin.
Streptozocin
Foscarnet may increase the nephrotoxic activities of Streptozocin.
Sulfisoxazole
Foscarnet may increase the QTc-prolonging activities of Sulfisoxazole.
Tacrolimus
Foscarnet may increase the nephrotoxic activities of Tacrolimus.
Telavancin
Foscarnet may increase the QTc-prolonging activities of Telavancin.
Telithromycin
Foscarnet may increase the QTc-prolonging activities of Telithromycin.
Tetrabenazine
Foscarnet may increase the QTc-prolonging activities of Tetrabenazine.
Thioridazine
Foscarnet may increase the QTc-prolonging activities of Thioridazine.
Tobramycin
Foscarnet may increase the nephrotoxic activities of Tobramycin.
Toremifene
Foscarnet may increase the QTc-prolonging activities of Toremifene.
Torsemide
Torasemide may decrease the excretion rate of Foscarnet which could result in a higher serum level.
Valacyclovir
Valaciclovir may increase the nephrotoxic activities of Foscarnet.
Valrubicin
Foscarnet may increase the nephrotoxic activities of Valrubicin.
Vandetanib
Foscarnet may increase the QTc-prolonging activities of Vandetanib.
Vemurafenib
Foscarnet may increase the QTc-prolonging activities of Vemurafenib.
Ziprasidone
Foscarnet may increase the QTc-prolonging activities of Ziprasidone.
Zuclopenthixol
Foscarnet may increase the QTc-prolonging activities of Zuclopenthixol.
